Skip to content
Home/Companies/MedTech/SIM AND CURE

SIM AND CURE

MedTech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns SIM AND CURE?

SIM AND CURE is currently owned by Irdi Capital-Investissement through IRDInov 3 (2023 vintage), since 2025.

Hand-verified · updated 2026-07-16

Irdi Capital-Investissement
Investor
Irdi Capital-Investissement
IRDInov 3 · 2023 · VC

Key facts

HQFrance
SectorMedTech
StatusActive

More from IRDInov 3

Other portfolio companies in the same fund.

DiappyMed
DiappyMed
Active
MedTechFrance· 2026
CORPO EVENTS
Corpo Events
Active
HospitalityFrance· 2025
Feedae
Active
SaaSFrance· 2025
PeopleSpheres
Active
HR TechFrance· 2025
APPVIZER
Appvizer
Active
SaaSFrance· 2024
BioC3
Active
BiotechFrance· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track SIM AND Cure

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy SIM AND Cure?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on SIM AND Cure.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue